XML 43 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
Collaboration agreements - Takeda partnership (Details)
$ in Thousands
1 Months Ended 49 Months Ended
Jan. 31, 2016
USD ($)
item
Jan. 31, 2016
USD ($)
item
Mar. 31, 2018
USD ($)
item
Mar. 31, 2014
USD ($)
item
2014, 2015 and 2016 Takeda Agreements        
Collaboration agreements        
Number of targets | item 7 7    
Fee payments received | $     $ 24,800  
Number of targets designated | item     4  
Number of targets for which Tokeda has limited replacement rights | item     2  
Amount to be received for second limited replacement right | $     $ 500  
Aggregate milestones | $     769,000  
Development milestones | $     79,000  
Regulatory milestones | $     239,000  
Commercial milestones | $     451,000  
Milestone on first designated target | $     136,000  
Milestone on each of the third, fifth sixth and seventh designated targets | $     $ 158,250  
Number of individual development milestones per target | item     4  
Number of individual commercial milestones | item     6  
Number of thresholds for annual net sales | item     3  
Next potential development milestone payment eligible to receive | $     $ 500  
Amount of next potential milestone receivable related to filing IND | $     $ 750  
2014, 2015 and 2016 Takeda Agreements | Minimum        
Collaboration agreements        
Number of individual regulatory milestones per target | item     6  
2014, 2015 and 2016 Takeda Agreements | Maximum        
Collaboration agreements        
Number of individual regulatory milestones per target | item     8  
2015 and 2016 Takeda Agreements        
Collaboration agreements        
Number of targets | item 5 5    
2014 Tokeda Agreement        
Collaboration agreements        
Number of targets | item       2
Amount of option exercise fee for designated targets | $       $ 1,300
2016 Restated Tokeda Agreement        
Collaboration agreements        
Number of products entity may elect to co-develop and co-commercialize | item 1 1    
Payment for option to co-develop and co-commercialize product | $ $ 15,000 $ 15,000    
Share of profit related to United States (as a percent) 50.00% 50.00%    
Costs incurred in United States (as a percent) 50.00% 50.00%    
Global development costs (as a percent) 30.00% 30.00%    
Costs incurred specifically for a foreign country borne by Takeda (as a percent) 100.00% 100.00%    
Prior written notice for termination period   45 days    
Number of targets with respect to breach | item 1